Pyronaridine
ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
Also known as: malaridine, pyronaridine tetraphosphate
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Pyronaridine is a drug catalogued in DrugCentral. Recorded indications include Falciparum malaria and Vivax malaria.
- Indications: Falciparum malaria and Vivax malaria.
- ATC code: P01BF06 (Artemisinin and derivatives, combinations).
- Molecular formula: C29H32ClN5O2; molecular weight 518.06 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Indications (2)
- Falciparum malaria
- Vivax malaria
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
P01BF06 | ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS › ANTIPROTOZOALS › ANTIMALARIALS › Artemisinin and derivatives, combinations |
Chemical structure
| Molecular formula | C29H32ClN5O2 |
|---|---|
| Molecular weight | 518.06 g/mol |
| CAS number | 74847-35-1 |
| InChIKey | DJUFPMUQJKWIJB-UHFFFAOYSA-N |
| PubChem CID | 107771 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is Pyronaridine used for?
DrugCentral lists the following indications for Pyronaridine: Falciparum malaria and Vivax malaria.
What is the chemical formula of Pyronaridine?
Pyronaridine has the molecular formula C29H32ClN5O2 and a molecular weight of 518.06 g/mol.
Browse: all drugs starting with P · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 4339 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL2095224 — compound record and bioactivity
- PubChem CID 107771 — chemical identifiers
- DrugBank DB12975 — drug record
- FDA UNII TD3P7Q3SG6 — substance identity
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.